Abstract
Elevated preoperative serum CA‐125 levels were present in three of four patients (75%) with Stage I uterine sarcoma found to have extrauterine spread of disease at laparotomy as well as five of seven (71%) patients with clinically advanced and recurrent uterine sarcoma. Serial levels during chemotherapy inconsistently reflected response to treatment and proved to have limited clinical value. Copyright © 1988 American Cancer Society
Cite
CITATION STYLE
APA
Patsner, B., & Mann, W. J. (1988). Use of serum CA‐125 in monitoring patients with uterine sarcoma: A preliminary report. Cancer, 62(7), 1355–1358. https://doi.org/10.1002/1097-0142(19881001)62:7<1355::AID-CNCR2820620719>3.0.CO;2-4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free